Difference between revisions of "Team:Bielefeld-CeBiTec/Notebook/PlasmidDisplay"

Line 56: Line 56:
 
                 <div class="panel-body">
 
                 <div class="panel-body">
 
  <p><ul><li>
 
  <p><ul><li>
                   Heat shock transformation of Biobricks needed for further assays was performed. Glycerol stocks were generated and the plasmids isolated according to the kits manual. The relevant Biobricks were: </li>
+
                   Heat shock transformation of BioBricks needed for further assays was performed. Glycerol stocks were generated and the plasmids isolated according to the kits manual. The relevant BioBricks were: </li>
 
<ul>
 
<ul>
<li>BBa_K525998: T7 promotor and RBS </li>
+
<li><a href="http://parts.igem.org/Part:BBa_K525998" target="_blank">BBa_K525998</a>: T7 promotor and RBS </li>
<li>BBa_C0012: lacI repressor with LVA Tag </li>
+
<li><a href="http://parts.igem.org/Part:BBa_C0012" target="_blank">BBa_C0012</a>: LacI repressor with LVA Tag </li>
<li>BBa_R0010: lac Promotor </li>
+
    <li><a href="http://parts.igem.org/Part:BBa_R0010" target="_blank">BBa_R0010</a>: <i>lac</i> Promotor </li>
<li>BBa_K592008: lac Operator </li>
+
    <li><a href="http://parts.igem.org/Part:BBa_K592008" target="_blank">BBa_K592008</a>: <i>lac</i> Operator </li>
 
</ul>
 
</ul>
<li>Furthermore, a plasmid with a gene coding for a his-tagged lacI Protein was transformed, which was kindly provided by Stefan Hoffmann.</li>
+
<li>Furthermore, a plasmid with a gene coding for a His-tagged LacI Protein was transformed, which was kindly provided by Stefan Hoffmann, University of Potsdam.</li>
 +
                    <ul><li>Coding sequence was equal to <a href="http://parts.igem.org/Part:BBa_C0012" target="_blank">BBa_C0012</a> except for the His-tag instead of the LVA-tag.</li></ul>
 
</ul>
 
</ul>
 
  </p>
 
  </p>
Line 80: Line 81:
 
                     <p>
 
                     <p>
 
<ul>  
 
<ul>  
<li>Purification of his-tagged lacI</li>
+
<li>Purification of His-tagged LacI</li>
<li>Test digest of transformed Biobricks: all clones as expected!</li>
+
    <ul><li>was performed according to the manual of the Protino® Ni-TED 1000 Packed Columns Kit from Macherey Nagel</li></ul>
<li>Plasmid isolation of BBa_R0010 and BBa_K592008 </li>
+
<li>Test digest of transformed BioBricks</li>
 +
    <ul><li>All fragment sizes corresponded to the expected ones.</li></ul>
 +
<li>Plasmid isolation of <a href="http://parts.igem.org/Part:BBa_R0010" target="_blank">BBa_R0010</a> and <a href="http://parts.igem.org/Part:BBa_K592008" target="_blank">BBa_K592008</a> </li>
 
</ul>
 
</ul>
  
Line 100: Line 103:
 
                     <p>
 
                     <p>
 
                         <ul>  
 
                         <ul>  
<li>Purification of his-tagged lacI to achieve higher purity was performed automatically with an FPLC from BioRad.</li>
+
<li>Purification of His-tagged LacI</li>
 +
                            <ul><li>purification was repeated to a higher purity</li><li>this time an FPLC from BioRad did the job</li><li>concentration of pure lacI: 5.59 mg/mL</li></ul>
  
<li>Plasmid isolation of BBa_R0010 and BBa_K592008 to generate enough material for our interaction assays.</li>
+
<li>Plasmid isolation of <a href="http://parts.igem.org/Part:BBa_R0010" target="_blank">BBa_R0010</a> and <a href="http://parts.igem.org/Part:BBa_K592008" target="_blank">BBa_K592008</a></li><ul><li>needed to be redone in order to generate enough material for our interaction assays.</li></ul>  
 
</ul>
 
</ul>
 
                     </p>
 
                     </p>
Line 119: Line 123:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Verification of lacI-His </li>
+
     <li>Verification of LacI-His </li>
 
     <ul>
 
     <ul>
         <li>SDS-PAGE for analyzing the purifity of purified lacI-His</li>
+
         <li>SDS-PAGE for analyzing the purity of purified LacI-His</li>
         <li>lacI-His was expected in the 38 kDa bands </li>
+
         <li>LacI-His was expected in the 38 kDa bands </li>
 
         <li>Bands (size 38 kDa) were cut out and destained. </li>
 
         <li>Bands (size 38 kDa) were cut out and destained. </li>
 
<figure>
 
<figure>
<img src="https://static.igem.org/mediawiki/2015/c/c7/Bielefeld-CeBiTec_PT-SDS-PAGE_lacI.png" alt="lacI" width="400px" style="margin-top: 20px">
+
<img src="https://static.igem.org/mediawiki/2015/c/c7/Bielefeld-CeBiTec_PT-SDS-PAGE_lacI.png" alt="LacI SDS-PAGE" width="400px" style="margin-top: 20px">
<figcaption>SDS-PAGE for the identification of lacI.</figcaption>
+
<figcaption>SDS-PAGE for the identification of LacI.</figcaption>
 
</figure>
 
</figure>
 
     </ul>
 
     </ul>
Line 144: Line 148:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>MS-Analysis of SDS-Page bands</li>
+
     <li>MS-Analysis of SDS-PAGE bands</li>
 
         <ul>
 
         <ul>
 
             <li>Tryptic digestion of the proteins from the bands. </li>
 
             <li>Tryptic digestion of the proteins from the bands. </li>
Line 166: Line 170:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Development of the plasmid repressor interaction assay (PRIA)</li>
+
     <li>Development of the Plasmid Repressor Interaction Assay (PRIA)</li>
 
     <ul>
 
     <ul>
 
         <li>After every step the reaction tubes were centrifuged with 1000 <i>g</i> for 1 minute.  
 
         <li>After every step the reaction tubes were centrifuged with 1000 <i>g</i> for 1 minute.  
<li>The supernatant after centrifugation was stored for analyzing protein and DNA amounts of the samples. </li>  
+
<li>The supernatant after centrifugation was stored at -20°C for subsequent analysis of protein and DNA amounts. </li>  
 
<li>The DNA amount of the supernatant after centrifugation was analyzed via nanodrop and the protein amount analyzed via SDS-PAGE. </li>
 
<li>The DNA amount of the supernatant after centrifugation was analyzed via nanodrop and the protein amount analyzed via SDS-PAGE. </li>
         <li>As negative controls we did not add protein to the agarose column in one sample and no plasmid in another sample.</li>
+
         <li>As negative controls we did not add protein to the Ni-NTA agarose in one sample and no plasmid in another sample.</li>
         <li>We tested the interaction of lacI with the lac promoter and lac operator.</li>
+
         <li>We tested the interaction of LacI with the <i>lac</i> promoter and <i>lac</i> operator.</li>
 
         <li>We also performed the complex formation at 0 °C and 37 °C</li>
 
         <li>We also performed the complex formation at 0 °C and 37 °C</li>
 
         <li>Steps: </li>
 
         <li>Steps: </li>
 
         <ul>
 
         <ul>
             <li>25 µL Ni-NTA agarose was put in a reaction tube. Then the sample was centrifuged. </li>
+
             <li>25 µL Ni-NTA agarose was put in a reaction tube. Then the tube was centrifuged. </li>
             <li>The agarose column was washed three times with potassium phosphate (Kpi) buffer. </li>
+
             <li>The Ni-NTA agarose was washed three times with 200 mM potassium phosphate (Kpi) buffer. </li>
             <li>10 µg protein (we used lac Repressor with a His-Tag as model protein) in 20 µL Kpi buffer was added and incubated for 30 min.  Then the sample was centrifuged.  </li>
+
             <li>10 µg protein (we used Lac Repressor (LacI) with a His-Tag as model protein) in 20 µL Kpi buffer was added and incubated for 30 min.  Then the sample was centrifuged.  </li>
 
             <li>The column with the protein was washed three times in Kpi Buffer (Volume: 27 µL). Then the sample was centrifuged.</li>
 
             <li>The column with the protein was washed three times in Kpi Buffer (Volume: 27 µL). Then the sample was centrifuged.</li>
             <li>1.5 µg plasmid (lacO) was mixed with 20 µL binding buffer and incubated with the column for 15 minutes. Then the sample was centrifuged.</li>
+
             <li>1.5 µg plasmid (<i>lacO</i>) was mixed with 20 µL binding buffer and incubated with the column for 15 minutes. Then the sample was centrifuged.</li>
 
             <li>Unbound DNA was washed away three times with a binding buffer. </li>
 
             <li>Unbound DNA was washed away three times with a binding buffer. </li>
             <li>3x elution with binding buffer and analytes (for this experiment: IPTG). </li>
+
             <li>3x elution with binding buffer and analyte (for this experiment: IPTG). </li>
             <li>Imidazol was used to release proteins from the agarose. </li>
+
             <li>Imidazole was used to release proteins from the Ni-NTA agarose. </li>
 
         </ul>
 
         </ul>
         <li>Unfortunately, the DNA concentration could not be measured by the nanodrop. Next time: analysis with gelelectrophoresis.</li>
+
         <li>The DNA concentration could not be measured by the nanodrop.</li>
 
     </ul>
 
     </ul>
 
</ul>
 
</ul>
Line 202: Line 206:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Plasmid isolation of <i>E. coli</i> KRX with pSB1C3-lacO </li>
+
     <li>Plasmid isolation of <i>E. coli</i> KRX with pSB1C3-<i>lacO</i> </li>
 
     <ul>
 
     <ul>
 
         <li>Concentration: 186,3 ng/µL</li>
 
         <li>Concentration: 186,3 ng/µL</li>
 
     </ul>
 
     </ul>
     <li>Suffix insertion: lacI-LVA as insert and pSB1C3-T7-RBS as backbone</li>
+
     <li>Suffix insertion: LacI-LVA as insert and pSB1C3-T7-RBS as backbone</li>
 
     <ul><li>The Standard protocol for suffix insertion was followed. Unfortunately unsuccessful</li></ul>
 
     <ul><li>The Standard protocol for suffix insertion was followed. Unfortunately unsuccessful</li></ul>
 
     <li>Optimizing PRIA</li>  
 
     <li>Optimizing PRIA</li>  
 
     <ul>
 
     <ul>
         <li> The DNA amount of the supernatant after centrifugation was analyzed via gelelectrophoresis.</li>
+
         <li> The DNA amount of the supernatant after centrifugation was analyzed via gel electrophoresis.</li>
 
         <li>Repetition of the assay performed before.</li>
 
         <li>Repetition of the assay performed before.</li>
 
<figure>
 
<figure>
Line 218: Line 222:
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/b/b7/Bielefeld-CeBiTec_PT-150604_PRIA.png" alt="150604" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/b/b7/Bielefeld-CeBiTec_PT-150604_PRIA.png" alt="150604" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. lacO can be released after the addition of IPTG.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. <i>lacO</i> can be released after the addition of IPTG.</figcaption>
 
</figure>
 
</figure>
<li>In the figure we could detect DNA after staining in ethidium bromide. </li>
+
<li>We could detect DNA after staining in ethidium bromide. </li>
 
         <li>A high DNA amount was unbound.</li>
 
         <li>A high DNA amount was unbound.</li>
         <li>Elution with IPTG possible. DNA could be detected after adding the analyte solution to the agarose.</li>
+
         <li>Elution with IPTG is possible. DNA could be detected in the samples after adding the analyte solution to the Ni-NTA agarose.</li>
 
         <li>We did not see any difference between the temperatures at which the formation of the DNA-protein complex was performed.</li>
 
         <li>We did not see any difference between the temperatures at which the formation of the DNA-protein complex was performed.</li>
         <li>Not adding protein to the agarose column is a good negative control.</li>
+
         <li>Not adding protein to the Ni-NTA agarose is a good negative control, to see that there is neither unspecific release of DNA in the elution steps nor unspecific interaction of the plasmid with the column. </li>
         <li>The rest of the agarose column after the final step was dissolved in 10 µL water and also used for the analysis via gelelectrophoresis.</li>
+
         <li>The rest of the Ni-NTA agarose after the final step was dissolved in 10 µL water and also used for the analysis via gel electrophoresis.</li>
 
     </ul>
 
     </ul>
     <li>Verification of protein amount in the supernatant of every step in the assay.</li>
+
     <li>Determination of protein amount in the supernatant of every step in the assay.</li>
 
     <ul>
 
     <ul>
 
         <li>Detection via SDS-PAGE</li>
 
         <li>Detection via SDS-PAGE</li>
         <li>No protein detected, except in the step where it was released with imidazole. this means that the signal we detect is due to release of the plasmid, not due to loss of protein.</li>
+
         <li>No protein detected, except in the step where it was eluted from the Ni_NTA agarose with imidazole. This means that the signal we detect is due to release of the plasmid, not due to loss of protein.</li>
 
     </ul>
 
     </ul>
 
</ul>
 
</ul>
Line 247: Line 251:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>PRIA: Testing analyte solution with different concentrations</li>
+
     <li>PRIA: Testing analyte solutions with different concentrations</li>
 
         <ul>
 
         <ul>
             <li>We wanted to test 0.05 mM, 0.5 mM and 5 mM IPTG mixed with binding buffer as elution buffer. </li>
+
             <li>We wanted to test 0.05 mM, 0.5 mM and 5 mM IPTG in binding buffer as elution buffer to determine the sensitivity of our procedure. </li>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/f/fc/Bielefeld-CeBiTec_PT-150609_PRIA-Water.png" alt="150622_PRIA-Water" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/f/fc/Bielefeld-CeBiTec_PT-150609_PRIA-Water.png" alt="150622_PRIA-Water" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in water to look whether salt is necessary for disrupting the unspecific linkage between the Ni-NTA agarose and unbound DNA.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in water to find out whether salt is necessary for disrupting the unspecific linkage between the Ni-NTA agarose and unbound DNA.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/7/72/Bielefeld-CeBiTec_PT-150609_PRIA-50nMIPTG.png" alt="150622_PRIA-50nMIPTG" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/7/72/Bielefeld-CeBiTec_PT-150609_PRIA-50nMIPTG.png" alt="150622_PRIA-50nMIPTG" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We release DNA from the DNA-protein complex by adding 50 nM IPTG in the binding buffer.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We release DNA from the DNA-protein complex by adding 50 µM IPTG in the binding buffer.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/2/2d/Bielefeld-CeBiTec_PT-150609_PRIA-500nMIPTG.png" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/2/2d/Bielefeld-CeBiTec_PT-150609_PRIA-500nMIPTG.png" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We release DNA from the DNA-protein complex by adding 500 nM IPTG in the binding buffer.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We release DNA from the DNA-protein complex by adding 500 µM IPTG in the binding buffer.</figcaption>
 
</figure>
 
</figure>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/0/0b/Bielefeld-CeBiTec_PT-150609_PRIA-5mMIPTG.png" alt="150622_PRIA-5mMIPTG" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/0/0b/Bielefeld-CeBiTec_PT-150609_PRIA-5mMIPTG.png" alt="150622_PRIA-5mMIPTG" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We release DNA from the DNA-protein complex by adding 5 mM IPTG in the binding buffer.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We release DNA from the DNA-protein complex by adding 5 mM IPTG in the binding buffer.</figcaption>
 
</figure>
 
</figure>
            <li>Small effect of the different IPTG concentrations to the eluted DNA amount. </li>
+
     <li>We standardized our assay. Every step took 15 minutes and the volume of the added solutions is 50 µL.</li>
     <li>We standardized our assay. Every step took 15 minutes and the volume of the added solutions are 50 µL.</li>
+
</ul><li>Cloning of His-tagged LacI in pSB1C3 backbone</li>
</ul>
+
    <ul>
     <li>Restriction of pSB1A3, pSB1C3-lacI-LVA and pSB1C3-T7-RBS for a 3A Assembly</li>
+
     <li>Restriction of pSB1A3, pSB1C3-LacI-LVA and pSB1C3-T7-RBS for a 3A Assembly</li>
     <li>Coating of an ELISA plate, to test if the protein can still perform its function if it is unspecifically immobilized </li>
+
    <li>Repetition of the suffix insertion, this time with success</li>
     <li>Preparation of an electrophoretic mobility shift assay (EMSA)</li>
+
    <li>Transformation in <i>E. coli</i> and subsequent plasmid isolation</li>
<ul><li>PCR for the creation of Cy3 labeled DNA fragments containing the lac operator, lac promoter, just T7 and RBS as a negative control and the ars operator.</li>
+
    <li>PCRs with split primers was performed to add the His-tag.Used primers:</li><ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_fwd" target="_blank">Cm_fwd</a></li>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_rev" target="_blank">Cm_rev</a></li>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacIhis0418_rv" target="_blank">lacIhis0418_rv</a></li>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacIhis0418_fw" target="_blank">lacIhis0418_fw</a></li>
 +
        </ul></ul>
 +
    <li>Evolution of PRIA</li><ul>
 +
     <li>Coating of an ELISA plate, to test if the protein can still perform its function if it is unspecifically immobilized </li></ul>
 +
     <li>Further evidence of LacI-<i>lacO</i> interaction</li>
 +
<ul>  <li>Preparation of an electrophoretic mobility shift assay (EMSA)</li></ul>  
 +
<ul><li>PCR for the creation of Cy3 labeled DNA fragments containing the lac operator, lac promoter, just T7 and RBS as a negative control and the ars operator.Used Primers:</li>
 +
    <ul>
 +
    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#VR" target="_blank">VR</a></li>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#VF-Cy3" target="_blank">VF-Cy3</a></li>
 +
    </ul>
 
</ul>
 
</ul>
 
</ul>
 
</ul>
Line 289: Line 307:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Interaction study of lacI-lacO via EMSA</li>
+
     <li>Interaction study of LacI-<i>lacO</i> via EMSA</li>
 
     <ul>
 
     <ul>
         <li>We performed an electrophoretic mobility shift assay with lacO and lacI</li>
+
         <li>We performed an electrophoretic mobility shift assay with <i>lacO</i> and LacI</li>
 
         <li> A shift was visible, but no clear band could be seen.</li>
 
         <li> A shift was visible, but no clear band could be seen.</li>
 
     </ul>
 
     </ul>
Line 310: Line 328:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Repetition of EMSA for lacO-lacI interaction </li>
+
     <li>Repetition of EMSA for <i>lacO</i>-LacI interaction </li>
     <ul><li>We added different amounts of the lacI, to achieve a clear shift of DNA band.</li>
+
     <ul><li>We added different amounts of the LacI, to achieve a clear shift of DNA band.</li>
 
     <li>The gel melted.</li></ul>
 
     <li>The gel melted.</li></ul>
 
     <li>Optimizing PRIA with different salt concentrations</li>
 
     <li>Optimizing PRIA with different salt concentrations</li>
 
     <ul>
 
     <ul>
         <li>Concentrations 100 mM, 250 mM and 500 mM KCl in binding buffer were tested in PRIA.</li>
+
         <li>Concentrations of 100 mM, 250 mM and 500 mM KCl in the binding buffer were tested in PRIA.</li>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/b/b0/Bielefeld-CeBiTec_PT-150622_PRIA-100mM.png" alt="150622_PRIA-100mM" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/b/b0/Bielefeld-CeBiTec_PT-150622_PRIA-100mM.png" alt="150622_PRIA-100mM" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 100 mM KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 100 mM KCl.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/a/a1/Bielefeld-CeBiTec_PT-150622_PRIA-250mM.png" alt="150622_PRIA-250mM" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/a/a1/Bielefeld-CeBiTec_PT-150622_PRIA-250mM.png" alt="150622_PRIA-250mM" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 250 mM KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 250 mM KCl.</figcaption>
 
</figure>
 
</figure>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/c/c4/Bielefeld-CeBiTec_PT-150622_PRIA-500mM.png" alt="150622_PRIA-500mM" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/c/c4/Bielefeld-CeBiTec_PT-150622_PRIA-500mM.png" alt="150622_PRIA-500mM" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 500 mM KCl.</figcaption>
 
</figure>
 
</figure>
 
         <li>Using binding buffer with 500 mM KCl was best for PRIA, because no plasmid remained on the column and a strong signal was visible in the first elution step.</li>
 
         <li>Using binding buffer with 500 mM KCl was best for PRIA, because no plasmid remained on the column and a strong signal was visible in the first elution step.</li>
Line 333: Line 351:
 
     <ul>
 
     <ul>
 
         <li>96 well plate as new system for PRIA</li>
 
         <li>96 well plate as new system for PRIA</li>
         <li>Unspecific adsorption of lacI.</li>
+
         <li>Unspecific adsorption of LacI.</li>
         <li>No elution of lacO. DNA was unbound. </li>
+
         <li>No elution of <i>lacO</i>. DNA was unbound. </li>
         <li>The plate was treated with the same procedure as the agarose column.</li>
+
         <li>The plate was treated with the same procedure as the Ni-NTA agarose.</li>
         <li>Analysis by SDS Page showed different bands, probably the BSA used for blocking of the ELISA plate was seen as well.</li>
+
         <li>Analysis by SDS-PAGE showed different bands, probably the BSA used for blocking of the ELISA plate was seen as well.</li>
 
     </ul>
 
     </ul>
  
Line 355: Line 373:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>PRIA with different salt concentrations and complex formation prior to adding the protein to the agarose column.</li>
+
     <li>PRIA with different salt concentrations and complex formation prior to adding the protein to the Ni-NTA agarose.</li>
 
     <ul>
 
     <ul>
         <li>We tried to create the complex of lacO and lacI first and then bound it on the agarose column. </li>
+
         <li>We tried to create the complex of <i>lacO</i> and LacI first and then bind it on the Ni-NTA agarose. </li>
         <li>We tested higher salt concentrations (0.5 M, 0.75 M, 1 M, 2 M KCl) in the binding buffer. Moreover, we examined whether we could also utilize sodium chloride. </li>
+
         <li>We tested higher salt concentrations (0.5 M, 0.75 M, 1 M, 2 M KCl) in the binding buffer. Moreover, we examined whether we could also utilize sodium chloride instead of potassium chloride. </li>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/9/9c/Bielefeld-CeBiTec_PT-150602_PRIA-500mMNaCl.png" alt="150702_PRIA-500mMNaCl" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/9/9c/Bielefeld-CeBiTec_PT-150602_PRIA-500mMNaCl.png" alt="150702_PRIA-500mMNaCl" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM NaCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 500 mM NaCl.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/7/7f/Bielefeld-CeBiTec_PT-150602_PRIA-500mM.png" alt="150702_PRIA-500mM" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/7/7f/Bielefeld-CeBiTec_PT-150602_PRIA-500mM.png" alt="150702_PRIA-500mM" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 500 mM KCl.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/3/39/Bielefeld-CeBiTec_PT-150602_PRIA-750mM.png" alt="150702_PRIA-750mM" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/3/39/Bielefeld-CeBiTec_PT-150602_PRIA-750mM.png" alt="150702_PRIA-750mM" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 750 mM KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 750 mM KCl.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/5/5e/Bielefeld-CeBiTec_PT-150602_PRIA-1M.png" alt="150702_PRIA-1M" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/5/5e/Bielefeld-CeBiTec_PT-150602_PRIA-1M.png" alt="150702_PRIA-1M" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 1 M KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 1 M KCl.</figcaption>
 
</figure>
 
</figure>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/6/6c/Bielefeld-CeBiTec_PT-150602_PRIA-2M.png" alt="150702_PRIA-2M" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/6/6c/Bielefeld-CeBiTec_PT-150602_PRIA-2M.png" alt="150702_PRIA-2M" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI and lacO. We washed the DNA-protein complex in binding buffer with 2 M KCl.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI and <i>lacO</i>. We washed the DNA-protein complex in binding buffer with 2 M KCl.</figcaption>
 
</figure>
 
</figure>
         <li>Sodium chloride could also used instead of potassium chloride, which could be useful in terms of usability.</li>
+
         <li>Sodium chloride could also be used instead of potassium chloride, which could be useful in terms of usability.</li>
 
   </ul>
 
   </ul>
     <li>Cloning of pSB1C3_T7-RBS-lacI-His</li>
+
     <li>Cloning of pSB1C3_T7-RBS-LacI-His</li>
     <ul><li>Transformation of pSB1C3_T7-RBS-lacI-Histag in <i>E. coli</i> KRX was successful.  
+
     <ul><li>Transformation of pSB1C3_T7-RBS-LacI-Histag in <i>E. coli</i> KRX was successful.  
 
Colonies were used to inoculate overnight cultures. </li></ul>
 
Colonies were used to inoculate overnight cultures. </li></ul>
 
</ul>
 
</ul>
Line 400: Line 418:
 
                     <p>
 
                     <p>
 
<ul>
 
<ul>
     <li>Repetition of EMSA with different protein concentration</li>
+
     <li>Repetition of EMSA with different protein concentrations</li>
 +
    <figure style="margin-bottom: 20px">
 +
<img src="https://static.igem.org/mediawiki/2015/e/e3/Bielefeld-CeBiTec_PT_EMSA_LacI.png" alt="LacI EMSA" width="200px">
 +
<figcaption>EMSA shift caused by given amount of LacI added to 0.05 pmol Cy3 labeled lacO fragment.</figcaption>
 +
</figure>
 
     <li>Test to bind DNA in filter paper</li>
 
     <li>Test to bind DNA in filter paper</li>
 
     <ul>
 
     <ul>
Line 408: Line 430:
 
         <li>No detection of DNA possible due to the high intrinsic signal of the paper strip. </li>
 
         <li>No detection of DNA possible due to the high intrinsic signal of the paper strip. </li>
 
     </ul>
 
     </ul>
     <li>We transformed BioBrick Bba_K1321340 from the distribution. It is a cellulose binding domain (CBD) which is reported to bind strongly to cellulose. </li>
+
     <li>We transformed a BioBrick for a cellulose binding domain (CBD) which is reported to bind strongly to cellulose. </li>
 
         <ul>
 
         <ul>
             <li>Transformation of Biobrick Bba_K1321340 in <i>E. coli</i> KRX</li>
+
             <li>Transformation of Biobrick <a href="http://parts.igem.org/Part:BBa_K1321340" target="_blank"> BBa_K1321340</a> in <i>E. coli</i> KRX</li>
 
             <li>Colony PCR of 5 clones on the agarplate after transformation. </li>
 
             <li>Colony PCR of 5 clones on the agarplate after transformation. </li>
 
             <li>5 colonies were used to inoculate overnight cultures. </li>
 
             <li>5 colonies were used to inoculate overnight cultures. </li>
Line 421: Line 443:
 
</li>
 
</li>
 
         </ul>
 
         </ul>
  <li>Primer design for cloning CBD and sfGFP to the devices arsR, blcR and lacI.</li>
+
  <li>Primer design for cloning CBD and sfGFP to the devices arsR, blcR and LacI.</li>
     <li>These are the devices we wanted to clone: </li>
+
     <li>These are the devices we wanted to clone (with these primers): </li>
 
     <ul>
 
     <ul>
         <li>pSB1C3-T7-RBS-lacI-sfGFP-His</li>
+
         <li>pSB1C3-T7-RBS-LacI-sfGFP-His</li>
 +
        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#C3-lacI-His-fw" target="_blank">Primer 1.1: C3-lacI-His-fw </a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#T7-RBS-lacI-rv" target="_blank">Primer 1.2: T7-RBS-lacI-rv</a></li>
 +
            <li>template 1: T7-RBS-lacI-His-tag</li>
 +
                    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacI-sfGFP-fw" target="_blank">Primer 2.1: lacI-sfGFP-fw</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacI-sfGFP-His-rv" target="_blank">Primer 2.2:lacI-sfGFP-His-rv</a></li>
 +
            <li>template 2: pSB1C3-T7-RBS-sfGFP</li>
 +
        </ul>
 
         <li>pSB1C3-T7-RBS-arsR-sfGFP-His</li>
 
         <li>pSB1C3-T7-RBS-arsR-sfGFP-His</li>
 +
                        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsR-L-sfGFP-rv" target="_blank">Primer 1.1: arsR-L-sfGFP-rv</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#V" target="_blank">Primer 1.2:T7-RBS-arsR-fw</a></li>
 +
            <li>template 1: pSB1C3_BBaJ33201</li>
 +
                    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#T7-RBS-arsR-rv" target="_blank">Primer 2.1: T7-RBS-arsR-rv</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#L-sfGFP-fw" target="_blank">Primer 2.2: L-sfGFP-fw </a></li>
 +
            <li>template 2: pSB1C3-T7-RBS-sfGFP </li>
 +
                            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_rev" target="_blank">Primer 3.1: Cm_rev</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#UberHis-arsR-fw" target="_blank">Primer 3.2: UberHis-arsR-fw</a></li>
 +
                                                        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_fwd" target="_blank">Primer 4.1: Cm_fwd</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsR-UberHis_rv" target="_blank">Primer 4.2: arsR-UberHis_rv</a></li>
 +
            <li>template 3: pSB1C3-T7-RBS-arsR-sfGFP</li>
 +
        </ul>
 
         <li>pSB1C3-T7-RBS-blcR-sfGFP-His</li>
 
         <li>pSB1C3-T7-RBS-blcR-sfGFP-His</li>
 +
        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#BlcR-T7-RBS-fw" target="_blank">Primer 1.1: BlcR-T7-RBS-fw</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#BlcR-L-sfGFP-rv" target="_blank">Primer 1.2:BlcR-L-sfGFP-rv</a></li>
 +
            <li>template 1: pSB1C3_blcR</li>
 +
                  <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#T7-RBS-arsR-rv" target="_blank">Primer 2.1: T7-RBS-arsR-rv</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#L-sfGFP-fw" target="_blank">Primer 2.2: L-sfGFP-fw </a></li>
 +
            <li>template 2: pSB1C3-T7-RBS-sfGFP </li>
 +
    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_rev" target="_blank">Primer 3.1: Cm_rev</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#UberHis-arsR-fw" target="_blank">Primer 3.2: UberHis-arsR-fw</a></li>
 +
                                                        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#Cm_fwd" target="_blank">Primer 4.1: Cm_fwd</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsR-UberHis_rv" target="_blank">Primer 4.2: arsR-UberHis_rv</a></li>
 +
            <li>template 3: pSB1C3-T7-RBS-blcR-sfGFP</li>
 +
        </ul>
 
         <li>pSB1C3-T7-RBS-arsR-CBD</li>
 
         <li>pSB1C3-T7-RBS-arsR-CBD</li>
 +
                <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsR-dCBD-fw" target="_blank">Primer 1.1: arsR-dCBD-fw </a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#CBD-eHisTerm-rv" target="_blank">Primer 1.2: CBD-eHisTerm-rv</a></li>
 +
            <li>template 1: pSB1C3_K1321340 </li>
 +
                    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsR-rv" target="_blank">Primer 2.1: arsR-rv</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#eHis-dTerm-fw" target="_blank">Primer 2.2: eHis-dTerm-fw</a></li>
 +
            <li>template 2: pSB1C3_T7-RBS-arsR-sfGFP</li>
 +
        </ul>
 
         <li>pSB1C3-T7-RBS-blcR-CBD</li>
 
         <li>pSB1C3-T7-RBS-blcR-CBD</li>
         <li>pSB1C3-T7-RBS-lacI-CBD</li>
+
                        <ul>
         <li>Cy3- and amino-labeled lacO operator</li>
+
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#bclR-CBD-fw" target="_blank">Primer 1.1: bclR-CBD-fw</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#CBD-eGFPTerm-rv " target="_blank">Primer 1.2: CBD-eGFPTerm-rv </a></li>
 +
            <li>template 1: pSB1C3_K1321340</li>
 +
                    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#eGFP-dTerm-fw" target="_blank">Primer 2.1: eGFP-dTerm-fw</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#bclR-rv" target="_blank">Primer 2.2: bclR-rv</a></li>
 +
            <li>template 2: pSB1C3_T7-RBS-blcR-sfGFP</li>
 +
        </ul>
 +
         <li>pSB1C3-T7-RBS-LacI-CBD</li>
 +
                        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacI-CBD-fw" target="_blank">Primer 1.1: lacI-CBD-fw </a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacI-CBD-Vektor-rv" target="_blank">Primer 1.2: lacI-CBD-Vektor-rv</a></li>
 +
            <li>template 1: pSB1C3_K1321340 </li>
 +
                    <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#EndHis-Vektor-lacI-fw" target="_blank">Primer 2.1: EndHis-Vektor-lacI-fw</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#lacI-rv" target="_blank">Primer 2.2: lacI-rv</a></li>
 +
            <li>template 2: pSB1C3_T7-RBS-lacI-HisTag </li>
 +
        </ul>
 +
         <li>Cy3- and amino-labeled <i>lacO</i> operator</li>
 +
        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#VF-Cy3" target="_blank">Primer 1: VF-Cy3</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#SuffixR-fw (amino labeled)" target="_blank">Primer 2: SuffixR-fw (amino labeled)</a></li>
 +
            <li>template 2: pSB1C3_T7-RBS-lacI-HisTag </li>
 +
        </ul>
 
         <li>Cy3- and amino-labeled ars operator</li>
 
         <li>Cy3- and amino-labeled ars operator</li>
 +
        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsO-rv (Cy3 labeled)" target="_blank">Primer 1: arsO-rv (Cy3 labeled)</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#arsO-fw (amino labeled)" target="_blank">Primer 2: arsO-fw (amino labeled)</a></li>
 +
            <li>Primers were annealed, no template necessary</li>
 +
        </ul>
 +
       
 
         <li>Cy3- and amino-labeled blc promoter</li>
 
         <li>Cy3- and amino-labeled blc promoter</li>
 +
        <ul>
 +
        <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#VF-Cy3" target="_blank">Primer 1: VF-Cy3</a></li>
 +
            <li><a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Primers#SuffixR-fw (amino labeled)" target="_blank">Primer 2: SuffixR-fw (amino labeled)</a></li>
 +
            <li>template 2: pSB1C3_Pblc </li>
 +
        </ul>
 
     </ul>
 
     </ul>
 
</ul>
 
</ul>
Line 452: Line 548:
 
<ul>
 
<ul>
 
     <li>Coating of a 96-well plate with microcrystalline cellulose. </li>
 
     <li>Coating of a 96-well plate with microcrystalline cellulose. </li>
     <ul><li>The instruction is from the iGEM team 2014 at Imperial university: 40 g cellulose is dissolved in 250 mL water. 200 µL cellulose solution is put in a well and incubated in an incubator (37 °C) overnight. We did a serial dilution to determine the optimal amount of cellulose per well. The optimal amount was 100 µL of a solution with 16 g/L avicell cellulose. </li>
+
     <ul><li>The instruction is from the iGEM team 2014 at Imperial university: 40 g cellulose is dissolved in 250 mL water. 200 µL cellulose solution is put in a well and incubated in an incubator (37 °C) overnight. We did a serial dilution to determine the optimal amount of cellulose per well. The optimal amount was 100 µL of a solution with 16 g/L Avicell cellulose. </li>
 
     </ul>
 
     </ul>
 
     <li>Cloning the devices for our new assays. </li>
 
     <li>Cloning the devices for our new assays. </li>
 
     <ul>
 
     <ul>
 
     <li>We ran several PCRs for cloning the devices mentioned before and extracted DNA out of gel. </li>
 
     <li>We ran several PCRs for cloning the devices mentioned before and extracted DNA out of gel. </li>
<li>We assembled the DNA through Gibson Assembly and transformed the assembled DNA in <i>E. coli</i> KRX. </li>
+
<li>We assembled the DNA through Gibson Assembly and transformed the assembled plasmids in <i>E. coli</i> KRX. </li>
 
         <li>Clones are evaluated through colony PCR. We cultivated several clones which contained the plasmid. </li>
 
         <li>Clones are evaluated through colony PCR. We cultivated several clones which contained the plasmid. </li>
 
          
 
          
Line 482: Line 578:
 
     <li>Cultivation</li>
 
     <li>Cultivation</li>
 
         <ul><li>
 
         <ul><li>
<i>E. coli</i> KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-lacO-sfGFP-His and pSB1C3-T7-RBS-blcR-sfGFP were cultivated and harvested to check whether the fusion proteins could be functionally expressed.Fluorescence of the pellets was detected via our special form of photography.</li>
+
<i>E. coli</i> KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-<i>lacO</i>-sfGFP-His and pSB1C3-T7-RBS-blcR-sfGFP were cultivated and harvested to check whether the fusion proteins could be functionally expressed.Fluorescence of the pellets was detected via our special form of photography.</li>
 
         </ul>
 
         </ul>
     <li>Preparation of necessary buffers for the activation of Paper.</li>
+
     <li>Immobilization of DNA</li>
 +
  <ul><li>Preparation of necessary buffers for the activation of Paper.</li></ul> 
 
</ul>
 
</ul>
 
</p>
 
</p>
Line 503: Line 600:
 
     <li>Immobilization of DNA on paper</li>
 
     <li>Immobilization of DNA on paper</li>
 
     <ul>
 
     <ul>
       <li>Whatman filter paper was activated through PDITC dissolved in DMSO. The DMSO was not dried properly, so the PDITC did not dissolve properly.</li>
+
       <li>Filter paper was activated by PDITC dissolved in DMSO. The DMSO was not dried, so the PDITC did not dissolve properly.</li>
         <li>Cy3- and amino-labeled DNA was immobilized on the activated paper and could be detected with the Typhoon scanner. It was created by hybridization od an amino labeled oligo and a Cy3 labeled oligo. After washing with water DNA signals were weaker. After washing with SSC buffer the signal vanished completly due to the denaturating effects of SSC. </li>
+
         <li>Cy3- and amino-labeled DNA was immobilized on the activated paper and could be detected with the Typhoon scanner. It was created by hybridization of an amino labeled oligo and a Cy3 labeled oligo. After washing with water the DNA signals were weaker. After washing with SSC buffer the signal vanished completely due to the denaturating effects of SSC. </li>
 
     </ul>     
 
     </ul>     
 
       <li>Cultivation</li>
 
       <li>Cultivation</li>
 
     <ul>
 
     <ul>
<li><i>E. coli</i> KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-lacO-sfGFP-His and  pSB1C3-T7-RBS-blcR-sfGFP were cultivated and were disrupted via sonification.</li>
+
<li><i>E. coli</i> KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-<i>lacO</i>-sfGFP-His and  pSB1C3-T7-RBS-blcR-sfGFP were cultivated and were disrupted via sonification.</li>
 
     </ul>
 
     </ul>
 
<li>Quantification of protein</li>
 
<li>Quantification of protein</li>
Line 530: Line 627:
 
                     <ul><li>PDITC was dissolved in ethanol and acetic acid, and used for activation of Paper. No washing with SSC buffer</li>
 
                     <ul><li>PDITC was dissolved in ethanol and acetic acid, and used for activation of Paper. No washing with SSC buffer</li>
 
                     <li>The oligos that are to be immobilized were in PCR buffer or 50 mM sodium phosphate buffer, pH 8.0. The oligos in the 50 mM sodium phosphate buffer performed better and were more resistant to washing.</li>
 
                     <li>The oligos that are to be immobilized were in PCR buffer or 50 mM sodium phosphate buffer, pH 8.0. The oligos in the 50 mM sodium phosphate buffer performed better and were more resistant to washing.</li>
                     <li>We blocked the membranes with the immobilized DNA with milk powder or BSA and </li></ul>
+
                     <li>We blocked the membranes with the immobilized DNA with milk powder or BSA</li></ul>
 
                     <li>Immobilization of protein</li>
 
                     <li>Immobilization of protein</li>
 
                     <ul><li>We planned to add the CBD fusion proteins to paper and wash the unbound protein off
 
                     <ul><li>We planned to add the CBD fusion proteins to paper and wash the unbound protein off
 
                         </li>
 
                         </li>
 
                         <li>Test for the visualization of protein on paper: Coomassie staining solutions and destaining solutions normally used for SDS PAGES worked just fine and stained the protein spots on paper specifically.</li>
 
                         <li>Test for the visualization of protein on paper: Coomassie staining solutions and destaining solutions normally used for SDS PAGES worked just fine and stained the protein spots on paper specifically.</li>
                         <li>The proteins bound strongly and unspecific to paper. We tested various buffers to remove them and washed over night. Nevertheless no diminishing of the coomassie signal was detected.</li>
+
                         <li>The proteins bound strongly and unspecific to paper. We tested various buffers to remove them and washed overnight. Nevertheless no diminishing of the coomassie signal was detected.</li>
 
                          
 
                          
 
                     </ul>
 
                     </ul>
                     <li>EMSA to check arsR for binding to DNA, successful clear band shift.</li>
+
                     <li>EMSA to check arsR for binding to DNA</li><ul><li> successful clear band shift.</li></ul>
 
                     <li>cloning of an T7-RBS-UTR-sfGFP-His device</li>
 
                     <li>cloning of an T7-RBS-UTR-sfGFP-His device</li>
 
                     </ul></p>
 
                     </ul></p>
Line 553: Line 650:
 
             <div id="collapseSeventeen" class="panel-collapse collapse">
 
             <div id="collapseSeventeen" class="panel-collapse collapse">
 
                 <div class="panel-body">
 
                 <div class="panel-body">
                     <p><ul><li>Purification of his tagged arsR and analysis via SDS-Page</li>
+
                     <p><ul><li>Purification of His-tagged ArsR and analysis via SDS-Page</li>
 
                     <li>Immobilized DNA in 96 well plate</li>
 
                     <li>Immobilized DNA in 96 well plate</li>
                     <ul><li>DNA was immobilized on the 96 well plate following the same protocol as for normal paper</li><li> 100 µL of the protein solution with 20 µg/ml were added to each well. The proteins were the GFP tagged fusion proteins.</li>
+
                     <ul><li>DNA was immobilized on the cellulose coated 96 well plate following the same protocol as for normal paper</li><li> 100 µL of the protein solution with 20 µg/ml were added to each well. The proteins were the GFP tagged fusion proteins.</li>
 
                     <li>the wells were washed with 200 µL of KBT buffer</li>
 
                     <li>the wells were washed with 200 µL of KBT buffer</li>
 
                     <li>90 µL of sample solution with a final concentration of 100 µg/ml was added.</li></ul>
 
                     <li>90 µL of sample solution with a final concentration of 100 µg/ml was added.</li></ul>
Line 578: Line 675:
 
     <li>Measurement in Tecan reader</li>
 
     <li>Measurement in Tecan reader</li>
 
     <ul>
 
     <ul>
         <li>We immobilised amino- and Cy3-labeled DNA on PDITC-activated paper in the 96 well plate, added arsI in every well and put analytes in the well.</li>
+
         <li>We immobilized amino- and Cy3-labeled DNA on PDITC-activated paper in the 96 well plate, added ArsR in every well and put analytes in the well.</li>
         <li>As we wanted to test the operator-repressor interaction and the effect of the analytes on the interaction we tested arsO-arsI, blcR-P<sub>blc</sub> and lacI-lacO. </li>
+
         <li>As we wanted to test the operator-repressor interaction and the effect of the analytes on the interaction we tested ArsR-<i>arsO</i>, blcR-P<sub>blc</sub> and LacI-<i>lacO</i>. </li>
 
      
 
      
 
         <li>Our samples were: </li>
 
         <li>Our samples were: </li>
 
         <ul>
 
         <ul>
             <li>3x operator DNA with repressor plus analytes<sub>2</sub></li>
+
             <li>3x operator DNA with repressor plus analytes</li>
             <li>3x operator DNA with repressor without analytes<sub>2</sub></li>
+
             <li>3x operator DNA with repressor without analytes</li>
 
             <li>1x immobilized operator DNA without repressor proteins</li>
 
             <li>1x immobilized operator DNA without repressor proteins</li>
 
             <li>3x blank</li>         
 
             <li>3x blank</li>         
 
         </ul>
 
         </ul>
         <li>For more information of the procedure, you can read the protocol<a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Protocols#Tecan"> "Measurement of fluorescence in plate reader"</a></li>
+
         <li>For more information on the procedure, you can read the protocol<a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Protocols#Tecan"> "Measurement of fluorescence in plate reader"</a></li>
 
      
 
      
 
     <li>Results</li>
 
     <li>Results</li>
 
         <ul>
 
         <ul>
             <li>The measurement on filter paper in a 96 well plate has not functioned. Reasons were:   
+
             <li>The measurement on filter paper in a 96 well plate did not deliver the expected results. Reasons were:   
 
                 <ul>
 
                 <ul>
 
                     <li>The measured data within a triplicate fluctuated. The differences of the GFP-fluorescence of the sample are too low. </li>
 
                     <li>The measured data within a triplicate fluctuated. The differences of the GFP-fluorescence of the sample are too low. </li>
Line 606: Line 703:
 
     </ul>
 
     </ul>
 
      
 
      
     <li>PRIA on Ni-NTA agarose for the interaction between lacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and P<sub>blc</sub> and arsR and arsO</li>
+
     <li>PRIA on Ni-NTA agarose for the interaction between LacI-sfGFP and <i>lacO</i>, arsR-sfGFP and <i>lacO</i>, blc-sfGFP and P<sub>blc</sub> and arsR and arsO</li>
 
         <ul>
 
         <ul>
     <li>We wanted to test the interaction between lacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and P<sub>blc</sub> and arsR and arsO.</li>
+
     <li>We wanted to test the interaction between LacI-sfGFP and <i>lacO</i>, arsR-sfGFP and <i>lacO</i>, blc-sfGFP and P<sub>blc</sub> and arsR and arsO.</li>
 
     <li>We tested the same conditions like in the protocol <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Protocols#PRIA">"PRIA protocols"</a> </li>
 
     <li>We tested the same conditions like in the protocol <a href="https://2015.igem.org/Team:Bielefeld-CeBiTec/Protocols#PRIA">"PRIA protocols"</a> </li>
     <li>As a positive control we immobilized lacI.</li>
+
     <li>As a positive control we immobilized LacI.</li>
     <li>The interactions could not be detected as DNA could not bind the protein and was washed out. </li>
+
     <li>DNA was detected in the imidazole step and on the Ni-NTA agarose, indicating that the DNA-protein complex was formed, but the binding could not be disrupted by the analyte. </li>
     <li>The reason could be that the protein binding site was complicated by the fusion of GFP. </li>
+
     <li>The reason could be that the analyte binding site was complicated by the fusion of GFP. </li>
 
     <li>Another reason is that the conditions are not appropriate for the interaction. </li>
 
     <li>Another reason is that the conditions are not appropriate for the interaction. </li>
 
     <li>We presumed that DTT needs to be added in every buffer to guarantee the reducing form of the protein. </li>
 
     <li>We presumed that DTT needs to be added in every buffer to guarantee the reducing form of the protein. </li>
 
         </ul>
 
         </ul>
 
      
 
      
     <li>Repetition of the PRIA on Ni-NTA agarose for the interaction between lacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and P<sub>blc</sub> and arsR and arsO</li>
+
     <li>Repetition of the PRIA on Ni-NTA agarose for the interaction between LacI-sfGFP and <i>lacO</i>, arsR-sfGFP and <i>lacO</i>, blc-sfGFP and P<sub>blc</sub> and arsR and arsO</li>
 
     <ul>
 
     <ul>
 
         <li>The test was negative again. So our presumption was wrong.</li>
 
         <li>The test was negative again. So our presumption was wrong.</li>
Line 638: Line 735:
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/f/f6/Bielefeld-CeBiTec_PT-150821_PRIA-arsRsfGFP2.png" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/f/f6/Bielefeld-CeBiTec_PT-150821_PRIA-arsRsfGFP2.png" width="400px">
<figcaption>Plasmid repressor interaction assay with arsR-sfGFP and arsO. We used 1x EMSA buffer as wash and binding buffer.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with arsR-sfGFP and arsO. We used 1x EMSA buffer as wash and binding buffer.</figcaption>
 
</figure>
 
</figure>
 
<figure>
 
<figure>
 
<img src="https://static.igem.org/mediawiki/2015/9/99/Bielefeld-CeBiTec_PT-150821_PRIA-lacIsfGFP.png" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/9/99/Bielefeld-CeBiTec_PT-150821_PRIA-lacIsfGFP.png" width="400px">
<figcaption>Plasmid repressor interaction assay with lacI-sfGFP and lacO. We used 1x EMSA buffer as wash and binding buffer.</figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with LacI-sfGFP and <i>lacO</i>. We used 1x EMSA buffer as wash and binding buffer.</figcaption>
 
</figure>
 
</figure>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/0/0a/Bielefeld-CeBiTec_PT-150821_PRIA-blcRsfGFP.png" alt="150821_PRIA-blcRsfGFP" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/0/0a/Bielefeld-CeBiTec_PT-150821_PRIA-blcRsfGFP.png" alt="150821_PRIA-blcRsfGFP" width="400px">
<figcaption>Plasmid repressor interaction assay with blcRsfGFP and P<sub>blc</sub>. We used 1x EMSA buffer as wash and binding buffer. </figcaption>
+
<figcaption>Plasmid Repressor Interaction Assay with blcRsfGFP and P<sub>blc</sub>. We used 1x EMSA buffer as wash and binding buffer. </figcaption>
 
</figure>
 
</figure>
 
                     <li>EMSA was performed to check whether a reaction to the analytes GBL, GHB or SSA could be seen for blcR</li>
 
                     <li>EMSA was performed to check whether a reaction to the analytes GBL, GHB or SSA could be seen for blcR</li>
 +
                    <ul><li>this was not the case</li></ul>
 
                     </ul></p>
 
                     </ul></p>
 
                 </div>
 
                 </div>
Line 662: Line 760:
 
             <div id="collapseTwenty" class="panel-collapse collapse">
 
             <div id="collapseTwenty" class="panel-collapse collapse">
 
                 <div class="panel-body">
 
                 <div class="panel-body">
                     <p><ul><li>We tested if our sfGFP arsR fusion protein would show FRET when interacting with the Cy3 labeled arsO. This was not the case.</li>
+
                     <p><ul><li>Interaction of fusion proteins with analytes</li><ul><li>We tested if our sfGFP arsR fusion protein would show FRET when interacting with the Cy3 labeled arsO. This was not the case. 1 µM solutions were measured in a nanofluorimeter and the heights of the peaks at 565 and 510 nm were compared.</li><li>The same procedure was performed for BlcR and P<sub>Blc</sub>. No FRET could be measured. Assumingly SSA quenched the fluorescence of GFP.</li></ul>
                     <li>The detection limit for GFP tagged proteins and Cy3 labeled DNA was determined by scanning of an serial dilution on paper in the Ettan DIGE</li>
+
                     <li>Immobilized Protein and DNA</li><ul><li>The detection limit for GFP tagged proteins and Cy3 labeled DNA was determined by scanning of an serial dilution on paper in the Ettan DIGE</li>
                     <li>By washing we determined the durability of the immobilized DNA on paper. Their was no difference between paper activated with PDITC dissolved in EtOH and PDITC dissolved in DMSO dried with molecular sieves. Therefore we recommend the activation of paper with PDITC dissolved in EtOH, which is easily available. Furthermore, the activated paper can be used up to two weeks after activation for the immobilization of DNA.</li></ul></p>
+
                     <li>By washing we determined the durability of the immobilized DNA on paper. Their was no difference between paper activated with PDITC dissolved in EtOH and PDITC dissolved in DMSO dried with molecular sieves. Therefore we recommend the activation of paper with PDITC dissolved in EtOH, which is easily available. Furthermore, the activated paper can be used up to two weeks after activation for the immobilization of DNA.</li></ul></ul></p>
 
                 </div>
 
                 </div>
 
             </div>
 
             </div>
Line 678: Line 776:
 
                 <div class="panel-body">
 
                 <div class="panel-body">
 
                     <p><ul>
 
                     <p><ul>
<li>Reproduction of PRIA on Ni-NTA agarose for lacO-lacI interaction</li>
+
<li>Reproduction of PRIA on Ni-NTA agarose for <i>lacO</i>-LacI interaction</li>
 
     <ul>
 
     <ul>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/b/b6/Bielefeld-CeBiTec_PT-150830-lacI1.png" alt="150830-lacI1" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/b/b6/Bielefeld-CeBiTec_PT-150830-lacI1.png" alt="150830-lacI1" width="400px">
<figcaption>PRIA with lacI and lacO.</figcaption>
+
<figcaption>PRIA with LacI and <i>lacO</i>.</figcaption>
 
</figure>
 
</figure>
  
Line 693: Line 791:
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/3/33/Bielefeld-CeBiTec_PT-Picogreen-lacO-triplicates.jpg" alt="Bielefeld-CeBiTec_PT-Picogreen-lacO-triplicates" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/3/33/Bielefeld-CeBiTec_PT-Picogreen-lacO-triplicates.jpg" alt="Bielefeld-CeBiTec_PT-Picogreen-lacO-triplicates" width="400px">
<figcaption>Figure A: Picogreen-Assay for the quantification of the samples of this week's PRIA on Ni-NTA agarose for lacO-lacI interaction.</figcaption>
+
<figcaption>Figure A: Picogreen-Assay for the quantification of the samples of this week's PRIA on Ni-NTA agarose for <i>lacO</i>-LacI interaction.</figcaption>
 
</figure>
 
</figure>
 
<figure style="margin-bottom: 20px">
 
<figure style="margin-bottom: 20px">
 
<img src="https://static.igem.org/mediawiki/2015/a/ac/Bielefeld-CeBiTec_PT-Picogreen-Buffer.jpg" alt="Bielefeld-CeBiTec_PT-Picogreen-Buffer" width="400px">
 
<img src="https://static.igem.org/mediawiki/2015/a/ac/Bielefeld-CeBiTec_PT-Picogreen-Buffer.jpg" alt="Bielefeld-CeBiTec_PT-Picogreen-Buffer" width="400px">
<figcaption>Figure A: Picogreen-Assay for the quantification of the samples of PRIA on Ni-NTA agarose for lacO-lacI interaction in week 11.</figcaption>
+
<figcaption>Figure B: Picogreen-Assay for the quantification of the samples of PRIA on Ni-NTA agarose for <i>lacO</i>-LacI interaction in week 11.</figcaption>
 
</figure>
 
</figure>
 
         <li>As you can see in figure A, most of the DNA is unbound and washing out unbound DNA is necessary to exclude falsification of the elution step. Three wash steps are needed, the forth wash step not.</li>
 
         <li>As you can see in figure A, most of the DNA is unbound and washing out unbound DNA is necessary to exclude falsification of the elution step. Three wash steps are needed, the forth wash step not.</li>
Line 703: Line 801:
 
         <li>You can also see in the imidazole step that DNA is barely bound to the protein. So almost every bound DNA plasmid is eluted. </li>
 
         <li>You can also see in the imidazole step that DNA is barely bound to the protein. So almost every bound DNA plasmid is eluted. </li>
 
<li>In figure B you can see that both binding buffers are equal. In the previous PRIA experiments we used the buffer with 500 mM.  
 
<li>In figure B you can see that both binding buffers are equal. In the previous PRIA experiments we used the buffer with 500 mM.  
         <li>All in all, the picogreen assay shows us that our developed plasmid repressor interaction assay works and that we can wash unbound DNA and elute bound DNA efficiently. </li>
+
         <li>All in all, the picogreen assay shows us that our developed Plasmid Repressor Interaction Assay works and that we can wash unbound DNA and elute bound DNA efficiently. </li>
 
    
 
    
 
     </ul>
 
     </ul>

Revision as of 19:08, 12 September 2015

iGEM Bielefeld 2015


Heavy metals Date rape drugs CFPS PRIA Miscellaneous

Plasmid Repressor Interaction Assay



  • Heat shock transformation of BioBricks needed for further assays was performed. Glycerol stocks were generated and the plasmids isolated according to the kits manual. The relevant BioBricks were:
  • Furthermore, a plasmid with a gene coding for a His-tagged LacI Protein was transformed, which was kindly provided by Stefan Hoffmann, University of Potsdam.
    • Coding sequence was equal to BBa_C0012 except for the His-tag instead of the LVA-tag.

  • Purification of His-tagged LacI
    • was performed according to the manual of the Protino® Ni-TED 1000 Packed Columns Kit from Macherey Nagel
  • Test digest of transformed BioBricks
    • All fragment sizes corresponded to the expected ones.
  • Plasmid isolation of BBa_R0010 and BBa_K592008

  • Purification of His-tagged LacI
    • purification was repeated to a higher purity
    • this time an FPLC from BioRad did the job
    • concentration of pure lacI: 5.59 mg/mL
  • Plasmid isolation of BBa_R0010 and BBa_K592008
    • needed to be redone in order to generate enough material for our interaction assays.

  • Verification of LacI-His
    • SDS-PAGE for analyzing the purity of purified LacI-His
    • LacI-His was expected in the 38 kDa bands
    • Bands (size 38 kDa) were cut out and destained.
    • LacI SDS-PAGE
      SDS-PAGE for the identification of LacI.

  • MS-Analysis of SDS-PAGE bands
    • Tryptic digestion of the proteins from the bands.
    • Measurement of the digested proteins via MALDI-TOF/TOF.
    • The measured peptide spectre was compared with spectre of other proteins with an E. coli database.
    • LacI identified (Mascot score: 765).

  • Development of the Plasmid Repressor Interaction Assay (PRIA)
    • After every step the reaction tubes were centrifuged with 1000 g for 1 minute.
    • The supernatant after centrifugation was stored at -20°C for subsequent analysis of protein and DNA amounts.
    • The DNA amount of the supernatant after centrifugation was analyzed via nanodrop and the protein amount analyzed via SDS-PAGE.
    • As negative controls we did not add protein to the Ni-NTA agarose in one sample and no plasmid in another sample.
    • We tested the interaction of LacI with the lac promoter and lac operator.
    • We also performed the complex formation at 0 °C and 37 °C
    • Steps:
      • 25 µL Ni-NTA agarose was put in a reaction tube. Then the tube was centrifuged.
      • The Ni-NTA agarose was washed three times with 200 mM potassium phosphate (Kpi) buffer.
      • 10 µg protein (we used Lac Repressor (LacI) with a His-Tag as model protein) in 20 µL Kpi buffer was added and incubated for 30 min. Then the sample was centrifuged.
      • The column with the protein was washed three times in Kpi Buffer (Volume: 27 µL). Then the sample was centrifuged.
      • 1.5 µg plasmid (lacO) was mixed with 20 µL binding buffer and incubated with the column for 15 minutes. Then the sample was centrifuged.
      • Unbound DNA was washed away three times with a binding buffer.
      • 3x elution with binding buffer and analyte (for this experiment: IPTG).
      • Imidazole was used to release proteins from the Ni-NTA agarose.
    • The DNA concentration could not be measured by the nanodrop.

  • Plasmid isolation of E. coli KRX with pSB1C3-lacO
    • Concentration: 186,3 ng/µL
  • Suffix insertion: LacI-LVA as insert and pSB1C3-T7-RBS as backbone
    • The Standard protocol for suffix insertion was followed. Unfortunately unsuccessful
  • Optimizing PRIA
    • The DNA amount of the supernatant after centrifugation was analyzed via gel electrophoresis.
    • Repetition of the assay performed before.
    • 150604_Negativ Control
      Negative control in which no proteins are bound to the Ni-NTA agarose. Plasmid DNA with the operator site cannot bind and is washed out.
      150604
      Plasmid Repressor Interaction Assay with LacI and lacO. lacO can be released after the addition of IPTG.
    • We could detect DNA after staining in ethidium bromide.
    • A high DNA amount was unbound.
    • Elution with IPTG is possible. DNA could be detected in the samples after adding the analyte solution to the Ni-NTA agarose.
    • We did not see any difference between the temperatures at which the formation of the DNA-protein complex was performed.
    • Not adding protein to the Ni-NTA agarose is a good negative control, to see that there is neither unspecific release of DNA in the elution steps nor unspecific interaction of the plasmid with the column.
    • The rest of the Ni-NTA agarose after the final step was dissolved in 10 µL water and also used for the analysis via gel electrophoresis.
  • Determination of protein amount in the supernatant of every step in the assay.
    • Detection via SDS-PAGE
    • No protein detected, except in the step where it was eluted from the Ni_NTA agarose with imidazole. This means that the signal we detect is due to release of the plasmid, not due to loss of protein.

  • PRIA: Testing analyte solutions with different concentrations
    • We wanted to test 0.05 mM, 0.5 mM and 5 mM IPTG in binding buffer as elution buffer to determine the sensitivity of our procedure.
    • 150622_PRIA-Water
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in water to find out whether salt is necessary for disrupting the unspecific linkage between the Ni-NTA agarose and unbound DNA.
      150622_PRIA-50nMIPTG
      Plasmid Repressor Interaction Assay with LacI and lacO. We release DNA from the DNA-protein complex by adding 50 µM IPTG in the binding buffer.
      Plasmid Repressor Interaction Assay with LacI and lacO. We release DNA from the DNA-protein complex by adding 500 µM IPTG in the binding buffer.
      150622_PRIA-5mMIPTG
      Plasmid Repressor Interaction Assay with LacI and lacO. We release DNA from the DNA-protein complex by adding 5 mM IPTG in the binding buffer.
    • We standardized our assay. Every step took 15 minutes and the volume of the added solutions is 50 µL.
  • Cloning of His-tagged LacI in pSB1C3 backbone
    • Restriction of pSB1A3, pSB1C3-LacI-LVA and pSB1C3-T7-RBS for a 3A Assembly
    • Repetition of the suffix insertion, this time with success
    • Transformation in E. coli and subsequent plasmid isolation
    • PCRs with split primers was performed to add the His-tag.Used primers:
  • Evolution of PRIA
    • Coating of an ELISA plate, to test if the protein can still perform its function if it is unspecifically immobilized
  • Further evidence of LacI-lacO interaction
    • Preparation of an electrophoretic mobility shift assay (EMSA)
    • PCR for the creation of Cy3 labeled DNA fragments containing the lac operator, lac promoter, just T7 and RBS as a negative control and the ars operator.Used Primers:

  • Interaction study of LacI-lacO via EMSA
    • We performed an electrophoretic mobility shift assay with lacO and LacI
    • A shift was visible, but no clear band could be seen.

  • Repetition of EMSA for lacO-LacI interaction
    • We added different amounts of the LacI, to achieve a clear shift of DNA band.
    • The gel melted.
  • Optimizing PRIA with different salt concentrations
    • Concentrations of 100 mM, 250 mM and 500 mM KCl in the binding buffer were tested in PRIA.
    • 150622_PRIA-100mM
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 100 mM KCl.
      150622_PRIA-250mM
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 250 mM KCl.
      150622_PRIA-500mM
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM KCl.
    • Using binding buffer with 500 mM KCl was best for PRIA, because no plasmid remained on the column and a strong signal was visible in the first elution step.
  • Test of PRIA in a 96 well plate for ELISA
    • 96 well plate as new system for PRIA
    • Unspecific adsorption of LacI.
    • No elution of lacO. DNA was unbound.
    • The plate was treated with the same procedure as the Ni-NTA agarose.
    • Analysis by SDS-PAGE showed different bands, probably the BSA used for blocking of the ELISA plate was seen as well.

  • PRIA with different salt concentrations and complex formation prior to adding the protein to the Ni-NTA agarose.
    • We tried to create the complex of lacO and LacI first and then bind it on the Ni-NTA agarose.
    • We tested higher salt concentrations (0.5 M, 0.75 M, 1 M, 2 M KCl) in the binding buffer. Moreover, we examined whether we could also utilize sodium chloride instead of potassium chloride.
    • 150702_PRIA-500mMNaCl
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM NaCl.
      150702_PRIA-500mM
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 500 mM KCl.
      150702_PRIA-750mM
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 750 mM KCl.
      150702_PRIA-1M
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 1 M KCl.
      150702_PRIA-2M
      Plasmid Repressor Interaction Assay with LacI and lacO. We washed the DNA-protein complex in binding buffer with 2 M KCl.
    • Sodium chloride could also be used instead of potassium chloride, which could be useful in terms of usability.
  • Cloning of pSB1C3_T7-RBS-LacI-His
    • Transformation of pSB1C3_T7-RBS-LacI-Histag in E. coli KRX was successful. Colonies were used to inoculate overnight cultures.

  • Coating of a 96-well plate with microcrystalline cellulose.
    • The instruction is from the iGEM team 2014 at Imperial university: 40 g cellulose is dissolved in 250 mL water. 200 µL cellulose solution is put in a well and incubated in an incubator (37 °C) overnight. We did a serial dilution to determine the optimal amount of cellulose per well. The optimal amount was 100 µL of a solution with 16 g/L Avicell cellulose.
  • Cloning the devices for our new assays.
    • We ran several PCRs for cloning the devices mentioned before and extracted DNA out of gel.
    • We assembled the DNA through Gibson Assembly and transformed the assembled plasmids in E. coli KRX.
    • Clones are evaluated through colony PCR. We cultivated several clones which contained the plasmid.

  • Plasmid isolation of the overnight cultures
    • All devices were sent to sequencing.
  • Cultivation
    • E. coli KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-lacO-sfGFP-His and pSB1C3-T7-RBS-blcR-sfGFP were cultivated and harvested to check whether the fusion proteins could be functionally expressed.Fluorescence of the pellets was detected via our special form of photography.
  • Immobilization of DNA
    • Preparation of necessary buffers for the activation of Paper.

  • Immobilization of DNA on paper
    • Filter paper was activated by PDITC dissolved in DMSO. The DMSO was not dried, so the PDITC did not dissolve properly.
    • Cy3- and amino-labeled DNA was immobilized on the activated paper and could be detected with the Typhoon scanner. It was created by hybridization of an amino labeled oligo and a Cy3 labeled oligo. After washing with water the DNA signals were weaker. After washing with SSC buffer the signal vanished completely due to the denaturating effects of SSC.
  • Cultivation
    • E. coli KRX with the plasmid pSB1C3-T7-RBS-arsR-sfGFP, pSB1C3-T7-RBS-lacO-sfGFP-His and pSB1C3-T7-RBS-blcR-sfGFP were cultivated and were disrupted via sonification.
  • Quantification of protein
    • Concentrations of the cell lysates with the fusion proteins were determined with Rotiquant.
    • An SDS PAGE was performed to check if the fusion proteins with a CBD were overexpressed. Unfortunately an overexpression could not been seen clearly.

  • Immobilization of DNA
    • PDITC was dissolved in ethanol and acetic acid, and used for activation of Paper. No washing with SSC buffer
    • The oligos that are to be immobilized were in PCR buffer or 50 mM sodium phosphate buffer, pH 8.0. The oligos in the 50 mM sodium phosphate buffer performed better and were more resistant to washing.
    • We blocked the membranes with the immobilized DNA with milk powder or BSA
  • Immobilization of protein
    • We planned to add the CBD fusion proteins to paper and wash the unbound protein off
    • Test for the visualization of protein on paper: Coomassie staining solutions and destaining solutions normally used for SDS PAGES worked just fine and stained the protein spots on paper specifically.
    • The proteins bound strongly and unspecific to paper. We tested various buffers to remove them and washed overnight. Nevertheless no diminishing of the coomassie signal was detected.
  • EMSA to check arsR for binding to DNA
    • successful clear band shift.
  • cloning of an T7-RBS-UTR-sfGFP-His device

  • Purification of His-tagged ArsR and analysis via SDS-Page
  • Immobilized DNA in 96 well plate
    • DNA was immobilized on the cellulose coated 96 well plate following the same protocol as for normal paper
    • 100 µL of the protein solution with 20 µg/ml were added to each well. The proteins were the GFP tagged fusion proteins.
    • the wells were washed with 200 µL of KBT buffer
    • 90 µL of sample solution with a final concentration of 100 µg/ml was added.
  • Immobilized DNA on Paper
    • We were able to detect the immobilized Cy3 labeled DNA and the GFP tagged Fusion proteins with an Ettan DIGE fluorescence scanner.
  • PRIA and EMSA for GFP tagged proteins was performed
    • The formation of the protein DNA complex was proven by both methods, nevertheless no release of DNA could be measured.

  • Measurement in Tecan reader
    • We immobilized amino- and Cy3-labeled DNA on PDITC-activated paper in the 96 well plate, added ArsR in every well and put analytes in the well.
    • As we wanted to test the operator-repressor interaction and the effect of the analytes on the interaction we tested ArsR-arsO, blcR-Pblc and LacI-lacO.
    • Our samples were:
      • 3x operator DNA with repressor plus analytes
      • 3x operator DNA with repressor without analytes
      • 1x immobilized operator DNA without repressor proteins
      • 3x blank
    • For more information on the procedure, you can read the protocol "Measurement of fluorescence in plate reader"
    • Results
      • The measurement on filter paper in a 96 well plate did not deliver the expected results. Reasons were:
        • The measured data within a triplicate fluctuated. The differences of the GFP-fluorescence of the sample are too low.
        • The release of the fusion protein after addition of the analytes is unspecific. So it does not matter if analytes are in the sample or not.
        • The binding buffer is not suitable for washing out unspecific binding. A high amount of fusion protein can be measured in the blank samples.
        • The amount of DNA is too low. After every wash step a little amount of immobilised DNA is released.
      • For a better and functional procedure, we have to test different buffer which can prevent unspecific interaction and stabilize the complex formation between the operator DNA and the repressor.
      • The difficulty is that you need different binding and elution conditions for interaction between repressor and operator DNA.
  • PRIA on Ni-NTA agarose for the interaction between LacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and Pblc and arsR and arsO
    • We wanted to test the interaction between LacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and Pblc and arsR and arsO.
    • We tested the same conditions like in the protocol "PRIA protocols"
    • As a positive control we immobilized LacI.
    • DNA was detected in the imidazole step and on the Ni-NTA agarose, indicating that the DNA-protein complex was formed, but the binding could not be disrupted by the analyte.
    • The reason could be that the analyte binding site was complicated by the fusion of GFP.
    • Another reason is that the conditions are not appropriate for the interaction.
    • We presumed that DTT needs to be added in every buffer to guarantee the reducing form of the protein.
  • Repetition of the PRIA on Ni-NTA agarose for the interaction between LacI-sfGFP and lacO, arsR-sfGFP and lacO, blc-sfGFP and Pblc and arsR and arsO
    • The test was negative again. So our presumption was wrong.

  • PRIA was repeated with conditions similar to those of EMSA
  • Plasmid Repressor Interaction Assay with arsR-sfGFP and arsO. We used 1x EMSA buffer as wash and binding buffer.
    Plasmid Repressor Interaction Assay with LacI-sfGFP and lacO. We used 1x EMSA buffer as wash and binding buffer.
    150821_PRIA-blcRsfGFP
    Plasmid Repressor Interaction Assay with blcRsfGFP and Pblc. We used 1x EMSA buffer as wash and binding buffer.
  • EMSA was performed to check whether a reaction to the analytes GBL, GHB or SSA could be seen for blcR
    • this was not the case

  • Interaction of fusion proteins with analytes
    • We tested if our sfGFP arsR fusion protein would show FRET when interacting with the Cy3 labeled arsO. This was not the case. 1 µM solutions were measured in a nanofluorimeter and the heights of the peaks at 565 and 510 nm were compared.
    • The same procedure was performed for BlcR and PBlc. No FRET could be measured. Assumingly SSA quenched the fluorescence of GFP.
  • Immobilized Protein and DNA
    • The detection limit for GFP tagged proteins and Cy3 labeled DNA was determined by scanning of an serial dilution on paper in the Ettan DIGE
    • By washing we determined the durability of the immobilized DNA on paper. Their was no difference between paper activated with PDITC dissolved in EtOH and PDITC dissolved in DMSO dried with molecular sieves. Therefore we recommend the activation of paper with PDITC dissolved in EtOH, which is easily available. Furthermore, the activated paper can be used up to two weeks after activation for the immobilization of DNA.

  • Reproduction of PRIA on Ni-NTA agarose for lacO-LacI interaction
    • 150830-lacI1
      PRIA with LacI and lacO.
    • We tested the interaction in triplicates and stored the samples for the quantification of DNA in the samples through picogreen-assay.
  • Picogreen-Assay for the quantification of DNA for PRIA
    • We wanted to quantify DNA in every sample to know how much DNA is unbound and eluted.
    • We measured the triplicates we made before and the elution samples.
    • Bielefeld-CeBiTec_PT-Picogreen-lacO-triplicates
      Figure A: Picogreen-Assay for the quantification of the samples of this week's PRIA on Ni-NTA agarose for lacO-LacI interaction.
      Bielefeld-CeBiTec_PT-Picogreen-Buffer
      Figure B: Picogreen-Assay for the quantification of the samples of PRIA on Ni-NTA agarose for lacO-LacI interaction in week 11.
    • As you can see in figure A, most of the DNA is unbound and washing out unbound DNA is necessary to exclude falsification of the elution step. Three wash steps are needed, the forth wash step not.
    • DNA can be eluted by adding the analytes. Most of the bound DNA is released after the first elution step.
    • You can also see in the imidazole step that DNA is barely bound to the protein. So almost every bound DNA plasmid is eluted.
    • In figure B you can see that both binding buffers are equal. In the previous PRIA experiments we used the buffer with 500 mM.
    • All in all, the picogreen assay shows us that our developed Plasmid Repressor Interaction Assay works and that we can wash unbound DNA and elute bound DNA efficiently.

Winter is coming, so we are preparing for Wiki-FREEZE!!